[article]
Titre : |
Asperger Syndrome and Medication Treatment |
Type de document : |
Texte imprimé et/ou numérique |
Auteurs : |
Luke Y. TSAI, Auteur |
Année de publication : |
2007 |
Article en page(s) : |
p.138-148 |
Langues : |
Anglais (eng) |
Index. décimale : |
PER Périodiques |
Résumé : |
Asperger syndrome (AS) is a neurobiological disorder whose core clinical symptoms include impairment in social interaction, impairments in verbal and nonverbal communication, and restricted, repetitive, and stereotyped patterns of behavior, interests, and activities. AS is often accompanied by coexisting neuropsychiatric disorders, including anxiety disorder, affective disorder, obsessive-compulsive disorder, Tourette syndrome, attention-deficit/hyperactivity disorder, and sleep disorders. These clinical features provide the rationale for the use of psychotropic medications (psychopharmacotherapy) in individuals with AS. This article describes the clinical indications for psychopharmacotherapy and provides guidelines for monitoring the effectiveness of medication treatment and for preventing and monitoring the development of side effects and/or adverse effects of psychotropic medications. |
En ligne : |
http://dx.doi.org/10.1177/10883576070220030101 |
Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=179 |
in Focus on Autism and Other Developmental Disabilities > 22-3 (Fall 2007) . - p.138-148
[article] Asperger Syndrome and Medication Treatment [Texte imprimé et/ou numérique] / Luke Y. TSAI, Auteur . - 2007 . - p.138-148. Langues : Anglais ( eng) in Focus on Autism and Other Developmental Disabilities > 22-3 (Fall 2007) . - p.138-148
Index. décimale : |
PER Périodiques |
Résumé : |
Asperger syndrome (AS) is a neurobiological disorder whose core clinical symptoms include impairment in social interaction, impairments in verbal and nonverbal communication, and restricted, repetitive, and stereotyped patterns of behavior, interests, and activities. AS is often accompanied by coexisting neuropsychiatric disorders, including anxiety disorder, affective disorder, obsessive-compulsive disorder, Tourette syndrome, attention-deficit/hyperactivity disorder, and sleep disorders. These clinical features provide the rationale for the use of psychotropic medications (psychopharmacotherapy) in individuals with AS. This article describes the clinical indications for psychopharmacotherapy and provides guidelines for monitoring the effectiveness of medication treatment and for preventing and monitoring the development of side effects and/or adverse effects of psychotropic medications. |
En ligne : |
http://dx.doi.org/10.1177/10883576070220030101 |
Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=179 |
|